Exciting CEO opportunity with the IBD Registry – could you be our first Chief Executive?
The IBD Registry is looking for an exceptional individual to help drive the next phase of its growth, as it expands to become a new legal entity, founded by the British Society of Gastroenterology (BSG), Crohn’s and Colitis UK and the Royal College of Physicians (RCP).
The Registry team have achieved significant success to date; the new Chief Executive Officer will build on these achievements, and lead the team through an exciting and crucial growth stage in the Registry’s development. The role involves:
- Heading up the operational team currently based near the RCP in London;
- Responsibility for the financial and executive direction of the Registry;
- With the Medical Director and the Board, setting the strategic direction of the new enterprise.
This is a fantastic opportunity to help shape a major UK initiative making a difference to the lives of people with Inflammatory Bowel Disease. Further details and a copy of the job pack can be found below.
Please share widely with your networks.
|CEO application pack||Download|
Applications close on Sunday 18th February at 19:00, with interviews planned to start on Tuesday 27th February 2018.
Find out more about:
The IBD Registry is recruiting three important posts to help its next phase of growth as one of the largest IBD registries in Europe. We are recruiting a Data Analytics Manager, a Projects and Operations Manager and a Data Analyst/ Developer. The roles will support...
The IBD Registry has published its first Annual Report on the Use of Biologics for Inflammatory Bowel Diseases for the year 2018-19. The report includes the cumulative results to January 2019 from April 2016 when the Registry assumed the role of supporting the National Audit of Biological Therapies from the Royal College of Physicians.
A £5m grant has been awarded by Health Data Research UK (HDR UK) to establish a health data research hub for inflammatory bowel disease (IBD). The IBD hub, to be known as Gut Reaction – The Health Data Research Hub for Inflammatory Bowel Disease, will bring together...
The IBD Registry is inviting UK IBD clinical centres to participate in a post-marketing safety study of patients using Zessly (infliximab), a biosimilar available for the treatment of Inflammatory Bowel Disease (IBD). This study is facilitated by the Registry on...
The IBD Registry is delighted a presentation prepared by the Registry’s Analytics Hub at the University of Liverpool featured in the British Society of Gastroenterology Annual Meeting in Glasgow. The Audit of biological therapy for IBD - Shawihdi et al Poster BSG 2019...